Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Abbott Laboratories, DexCom Inc., GlySens Incorporated

Registering a CAGR of 15.2% over the forecast period, the market value of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) is expected to reach US$ 8.9 billion in the year 2027.

Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Overview

An insulin pump is a tiny device that can deliver insulin for carbohydrate intake either continuously (basal) or quickly (bolus). You can also repair a high blood glucose level by typing your blood glucose or the amount of carbs you want to eat into the insulin pump. On the market, there are a range of insulin pumps to choose from, each with its own set of features. It’s important to begin with realistic expectations about what an insulin pump can and cannot do. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. A CGM requires a small sensor which is inserted under the skin into fatty tissue.  The sensor is connected to a transmitter that sends information to a receiver or smartphone 

The spike in the senior population and the high prevalence of diabetes in the population are two main factors driving the growth. According to the International Diabetes Federation, the number of diabetic patients worldwide is anticipated to increase to 650 million by 2040, up from 435 million in 2018. As a result, by 2040, one out of every 10 persons is anticipated to have diabetes, demonstrating the seriousness of the pandemic. As a result, diabetes treatment and management are projected to be a top priority for healthcare administrations and stakeholders around the world. The rise in diabetic cases is predicted to drive market growth and potential for continuous glucose monitoring systems, which will attract and compel various industry participants to produce innovative goods or services.

The report aspects discussed the profile of the top manufacturers of the global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.

Industry News and Updates:

• June 29, 2020--ABBOTT AND TANDEM DIABETES CARE ADVANCE DEVELOPMENT OF INTEGRATED TECHNOLOGIES FOR FUTURE AUTOMATED INSULIN DELIVERY SYSTEMS-
  
  Abbott (NYSE: ABT) and Tandem Diabetes Care (NASDAQ: TNDM) announced today that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems to provide more options for people to manage their diabetes. The companies first announced their intention to work together in October 2019, and this resulting agreement covers the technical development of device integration and associated commercial support activities.

• Feb. 19, 2020-- Dexcom and Insulet Announce Commercial Agreement to Integrate the Dexcom G6 and Future G7 CGM into Insulet’s Omnipod Horizon™ Automated Insulin Delivery System-
  
  DexCom, Inc. (NASDAQ: DXCM) and Insulet Corporation (NASDAQ: PODD), have announced a global commercialization agreement to combine current and future Dexcom continuous glucose monitoring systems (CGM) with Insulet’s trusted tubeless insulin delivery Pod into the Omnipod Horizon™ System for automated insulin delivery, currently in pivotal trial.

What are the major Applications, Types and Regions for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Insulin Pump


• Continuous Glucose Monitors (CGM)

By Application, it is segmented into

• Child


• Adult


• Elderly

Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Regional Analysis

North America is expected to dominate the insulin pump and CGM market share during the forecast period as the region is home to some of the biggest medical device manufacturers, such as Insulet and Tandem. Even European firms like Medtronic have acquired a substantial presence in the United States and Canada, encouraging regional market growth. The North American market is expected to be worth USD 3.5 billion in 2020. The rising prevalence of diabetes is expected to fuel the market in Europe. The rising incidence of diabetes and an increasing number of older people, particularly in Japan, who are at risk of acquiring chronic metabolic disorders, will drive the adoption of insulin pumps in Asia Pacific.

All these factors greatly affect the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market report scope?

Scope of the Report covers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market with detailed analysis of the overall scenario for the market. It also highlights the business participants environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market analysis report as it has vital details to provide about regional markets, expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how worldwide market is working through efficient information graphics.

Key Takeaways from this Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Report

• Evaluate Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market entropy - M&A's, deals, partnerships, product launches of all key players for the past 5 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the study period of this market?

The Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market is studied from 2017 - 2027.

What is the growth rate of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market?

The Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market is growing at a CAGR of 15.2% over the next 5 years.

Who are the key players in Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market?

Abbott Laboratories (NYSE: ABT), DexCom, Inc. (Nasdaq:DXCM), GlySens Incorporated, Insulet Corporation (Nasdaq:PODD), Johnson & Johnson(NYSE: JNJ), Medtronic PLC(NYSE: MDT), Meiqi Medical Equipment, MicroPort Scientific Corporation (OTC:MCRPF), Roche Holding AG ADR(OTC: RHHBY), Senseonics Holdings, Inc. (NYSE:SENS), SOOIL, Tandem Diabetes Care, Inc. (NasdaqGM:TNDM)

What regions does this Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market report covers?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market?

Insulin Pump, Continuous Glucose Monitors (CGM)

What are the major end-use applications of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market?

Child, Adult, Elderly

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.